
Insulin Developer and Manufacturer
Digital Power Drives Change, Innovation Empowers Healthy China
BeijingMay 16, 2023/PR Newswire/ --May 15, 2023Novo Nordisk Announces Launch of Digital Innovation Hub in China to Accelerate the Potential of China's Innovative Healthcare Development in the Digital Era. As a crucial part of Novo Nordisk’s global digital innovation strategy, the Digital Innovation Hub in China will focus on cutting-edge solutions in digital healthcare, fully explore market development needs, and help more advanced technologies gain traction through collaboration with local startups on pilot projects, thereby promoting the development of China's digital healthcare industry.

Launch Ceremony of Novo Nordisk Digital Innovation Hub (DIH)
Xiaping Zhou, Senior Vice President of Novo Nordisk Global and President of Greater China; Matt Dugan, Vice President of Global Digital Innovation; Dan Han, Corporate Vice President of Novo Nordisk Global and President of China R&D Center; Lars Arnoldsen (An Nuo Sheng), Corporate Vice President of Novo Nordisk Global and President of Tianjin Production Plant; Xiaomin Wu, Vice President of the Greater China Digital Health Center; Jing Ma, Head of China Digital Innovation Center; Ruihong Yang, Partner of Yuan Yi Capital; and the China management team attended the launch ceremony. They discussed trends in China’s digital healthcare and Novo Nordisk’s path to digital innovation.
"2023 is a milestone year. This year marks the 100th anniversary of Novo Nordisk's founding. For a hundred years, our original aspiration has remained unchanged, our mission has been shouldered, and our commitment continues. The establishment of Novo Nordisk’s China Digital Innovation Center will empower us to better fulfill our mission in this new century, deeply participate in the integration and co-creation of China's biopharmaceutical and health industry ecosystem, and join hands with the most dynamic local innovative forces in China to provide better medical services for patients."
Matt Dugan, Vice President of Global Digital Innovation at Novo Nordisk, stated: "Novo Nordisk aims to enhance the corporate health technology ecosystem and strengthen the entire industry chain layout by launching digital innovation hubs in China, the UK, Germany, Brazil, and Israel. By establishing deeper connections with more innovative companies and creating pilot projects, we will continuously optimize and explore advanced technical solutions to further drive breakthroughs in our operations within the Chinese market."
Rooted Internally, Co-created Externally: Accelerating the Release of China's Healthcare Innovation Potential in the Digital Era
Greater China has grown to become Novo Nordisk's second-largest market globally. In the next three to five years, Novo Nordisk China will pursue more diversified innovations, including digital innovation, medical device innovation, and pharmaceutical innovation. Novo Nordisk China will continue to deepen its presence and participate more extensively in the global healthcare value chain. The China Digital Innovation Hub will be one of the key drivers of future growth.

Novo Nordisk China Digital Innovation Hub (DIH) Launch Ceremony
Harry Dan, Global Corporate Vice President and President of R&D Center at Novo Nordisk, stated: "Through past collaborations between our R&D center in China and local innovative forces, we have witnessed the tremendous vitality of China's innovative enterprises. We look forward to working with the Digital Innovation Center to explore more digital innovation technologies for Novo Nordisk through internal embedding and external co-creation, enhancing the efficiency of R&D transformation and accelerating the drug development process."
Lars Arnoldsen (An Nuo Sheng), Global Corporate Vice President of Novo Nordisk and President of the Tianjin Production Plant, stated: "Digital technology helps pharmaceutical companies unlock more possibilities for industry development. The establishment of the China Digital Innovation Center will further accelerate our research, development, and application of modern technologies, assisting us in achieving further process optimization."
A Century of Unchanged初心, Driving Future Growth with创新力量
As people's health awareness gradually increases and the demand for medical services continues to grow, digital transformation has become an inevitable trend for medical enterprises. Yang Ruihong, partner of Yuan Yi Capital, stated at the launch ceremony that the digital process will reconstruct the medical ecosystem. Meanwhile, the development of digital healthcare in China is showing a characteristic of "a hundred flowers blooming," with various digital infrastructure continuously improving, the transformation of clinical scientific and technological achievements accelerating, and systems for precise diagnosis, intelligent payment, and insurance claims constantly optimizing, driving China's digital healthcare industry toward higher levels, deeper layers, and broader fields.
At Novo Nordisk China, digital innovation has become part of our entire innovation system, providing continuous momentum for the company's digital transformation. Wu Xiaomin, Vice President of the Digital Health Center at Novo Nordisk Greater China, stated: "The Digital Health Hub (DHH) and the Digital Innovation Hub (DIH) will work closely together, skillfully combining the company’s business needs with advancements in digital technology to continuously develop innovative solutions with sustainable business value."
Ma Jing, head of China's Digital Innovation Hub (DIH), stated: "After the establishment of China DIH, it will serve the entire industrial chain of the company, connect with partners in China's innovation ecosystem, deeply explore advanced digital healthcare technologies, and at the same time, build commercialization channels by consolidating internal and external resources to transform innovative achievements into practical solutions and products, enhancing patient service capabilities."
Novo Nordisk China Digital Innovation Hub will be committed to fulfilling the company's mission, driving change, and joining hands to combat diabetes and other serious chronic diseases. A series of activities will be launched soon. Ecosystem partners and startups interested in collaboration are welcome to contact us. Together, let’s accelerate digital innovation and advance towards the future of healthcare.